Modulator for promoting binding of butyrophilin 3a1/2a1
AssigneeUnicet Biotech Co. LLC.
InventorsWeiwei Ma, Yonghua XIE, Yinqiang SUI, Hui ZHANG, Rui HAO
Life of this patent
Estimating the term…
Abstract
A compound of formula (I) or a pharmaceutically acceptable salt, an enantiomer, a diastereomer, a solvate, a hydrate, a polymorph or an isotopic variant thereof, which can promote binding of butyrophilin 3A1/2A1, wherein the definitions of groups are as detailed in the description and the claims. Also involved are a pharmaceutical composition containing the compound of formula (I) and use thereof in clinical treatment.
Claims25
A compound of formula (X), or a pharmaceutically acceptable salt, an enantiomer, a diastereomer, a solvate, a hydrate, a polymorph or an isotopic variant thereof:
- wherein,
- ring A is C6-10 aryl or 5- to 10-membered heteroaryl;
- Ra is selected from
- X is O or CRR′;
- Y is O, NH or CH2;
- Z is O or NH;
- R1 is selected from H, F, Cl, CN, C1-4 alkyl, C2-4 alkenyl and C2-4 alkynyl, which are optionally substituted with 1-9 substituents independently selected from halogen, CN, OH and NH2;
- R2 is selected from C1-6 alkyl, C1-6 haloalkyl, C2-6 alkenyl, C2-6 alkynyl, C0-6 alkylene-C3-12 cycloalkyl, C0-6 alkylene-4- to 12-membered heterocyclyl, C0-6 alkylene-C6-10 aryl and C0-6 alkylene-5- to 12-membered heteroaryl;
- R3 is selected from H, C1-4 alkyl and C1-4 haloalkyl;
- R4 is selected from H, C1-4 alkyl, C1-4 haloalkyl, —C(O)R″, —C(O)OR″, —C(O)NR″R″, C0-6 alkylene-C3-7 cycloalkyl, C0-6 alkylene-3- to 7-membered heterocyclyl, C0-6 alkylene-C6-10 aryl and C0-6 alkylene-5- to 10-membered heteroaryl;
- or R3, R4 and the nitrogen atom to which they are attached are taken together to form a 4- to 7-membered heterocyclyl;
- R5 is selected from —(CH2CH2O)nCH3, C1-10 alkyl, C1-10 haloalkyl, C2-6 alkenyl, C2-6 alkynyl, C0-6 alkylene-C3-7 cycloalkyl, C0-6 alkylene-3- to 7-membered heterocyclyl, C0-6 alkylene-C6-10 aryl and C0-6 alkylene-5- to 10-membered heteroaryl;
- R6 is selected from C1-6 alkyl, C1-6 haloalkyl, C2-6 alkenyl and C2-6 alkynyl;
- wherein,
- R and R′ are independently selected from H and halogen;
- R″ is independently selected from H, C1-6 alkyl, C1-6 haloalkyl, C0-6 alkylene-C6-10 aryl and C0-6 alkylene-5- to 10-membered heteroaryl;
- n=1, 2, 3, 4, 5, or 6.
(canceled)
A compound, or a pharmaceutically acceptable salt, an enantiomer, a diastereomer, a solvate, a hydrate, a polymorph or an isotopic variant thereof, wherein the compound is selected from:
(canceled)
(canceled)
(canceled)
(canceled)
Dependencies are inferred from the claim text.